Skip to main content
Caplight Logo









SPARTHA Medical

SPARTHA Medical

Private
StrasbourgHealthcare & Life Scienceshttps://sparthamedical.eu/

Last Round

Grant

Jan 25, 2022

Total Funding Raised

$4.35M

Company Overview

SPARTHA Medical is a biotechnology company that designs, produces, and markets innovative multifunctional solutions that safeguard against infections and enhance wound healing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

antimicrobial coatingsmedical device coatingsbiopolymer coatingsbiomaterialsinfection preventionantibiotic resistanceanti-inflammatory coatingsnon-leaching coatingsco-development servicesimplant coatingsbiocompatibility testingAI for formulationantiviral coatingssupramolecular chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPARTHA Medical Comparables

Compare SPARTHA Medical with similar companies based on industry and business-model similarity.

SPARTHA Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orthobond Corporation
83%
Allvivo Vascular
82%
CytaCoat AB
82%

SPARTHA Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 25, 2022
VC RoundJan 25, 2022
SeedDec 8, 2021

Key People

Founding team and executive leadership

Nihal Engin Vrana

CEO

Executive Team

SPARTHA Medical Investors

Notable investors and investment history

SPARTHA Medical investors
InvestorRounds
European Innovation Council FundGrant, VC Round
Alsace Business AngelsSeed
YeastSeed
WiSeedSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Grew 29% QoQ, from 21 to 27 employees.

  • May 1, 2025

    Monthly visitors increased 54% MoM.

SPARTHA Medical Filings

Explore SEC and related filing metadata, where available.

SPARTHA Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SPARTHA Medical's valuation, stock price, and market status.

Is SPARTHA Medical a public or private company?

SPARTHA Medical is a private company.

What is the current stock price of SPARTHA Medical?

SPARTHA Medical is a private company with no public stock price. No recent secondary market data is available.

How much is SPARTHA Medical worth (valuation)?

Valuation information for SPARTHA Medical is not publicly available.

Can I buy SPARTHA Medical stock?

SPARTHA Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SPARTHA Medical's last funding round?

SPARTHA Medical's most recent funding round was Grant on January 25, 2022.

Who are the main investors in SPARTHA Medical?

Key investors in SPARTHA Medical include European Innovation Council.

Will SPARTHA Medical IPO soon?

No public IPO plans have been announced for SPARTHA Medical.

How can I track SPARTHA Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SPARTHA Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStrasbourg
Employee Range20
Year Founded2019
Last FundingJan 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?